Press Releases

TRENTON, N.J., Feb. 11, 2020 /PRNewswire/ -- New Jersey's life sciences community came out for BioNJ's 27th Annual Dinner Meeting & Innovation Celebration that took place last Thursday, February 6, at the Hilton East Brunswick. Dedicated to "Patients... Because they just can't wait," the

KING OF PRUSSIA, Pa., Feb. 11, 2020 /PRNewswire/ -- Global biotherapeutics leader CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has granted Privigen®

Corporate positions decreased by approximately 33% and operational positions decreased by approximately 13% Total number of positions decreased by approximately 15% across the Company New structure focuses the business on accelerating revenue growth in the Canadian market TORONTO, Feb. 11, 2020 /PRNewswire/ -

SHANGHAI, Feb. 11, 2020 /PRNewswire/ -- As the novel coronavirus epidemic continues to evolve in China, the country has introduced controls to prevent the spread of the epidemic and reduce the risk of contagion. Among the measures adopted is home quarantine, which has created challenges for patients with chronic diseases requiring visits

CHELMSFORD, Mass., Feb. 11, 2020 /PRNewswire/ -- Brooks Automation, Inc. (Nasdaq: BRKS) announced today that it has acquired RURO, Inc., an informatics software company based in Frederick, Maryland.  The total cash purchase price of the acquisition was $15 million, subject to customary working capital a

LONG BEACH, Calif., Feb. 11, 2020 /PRNewswire/ -- The Miller Children's Hospital Long Beach Auxiliary pledged

DUBLIN, Ohio, Feb. 11, 2020 /PRNewswire/ -- The Cardinal Health (NYSE: CAH) board of directors today approved a quarterly dividend of $0.4811 per share. The dividend will be payable on April 15, 2020, to shareholders of record at the close of business on April 1, 2020.

SAN FRANCISCO, Feb. 11, 2020 /PRNewswire/ -- Data and analytics platform Premise Data announced today it has collected data about COVID-19, formerly known as the Coronavirus, from ov

NEW BRUNSWICK, N.J., Feb. 11, 2020 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced that its Janssen Pharmaceutical Companies will further expedite its investigational coronavirus vaccine program through an expanded collaboration with the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary f

CARLSBAD, Calif., Feb. 11, 2020 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced net income of $476,000, or $0.07 per diluted share. Net sales during the three month